Key Insights

Highlights

Success Rate

50% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 87/100

Termination Rate

27.8%

5 terminated out of 18 trials

Success Rate

50.0%

-36.5% vs benchmark

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed with results

Key Signals

2 with results50% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (8)
P 2 (2)
P 3 (1)

Trial Status

Completed5
Terminated5
Recruiting3
Unknown2
Not Yet Recruiting1
Withdrawn1

Trial Success Rate

50.0%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT06501118Not ApplicableRecruiting

Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients

NCT04415060Phase 3Active Not Recruiting

SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival

NCT06140056Not ApplicableTerminatedPrimary

Two Modes of Mechanical Ventilation for Intensive Care Patients With Low Blood Oxygen Due to Breathing Difficulties

NCT03835741Not ApplicableTerminated

Automated Adjustment of Oxygen on Patient With Acute COPD Exacerbation - FreeO2 HypHop

NCT07099144Recruiting

Inhaled Nitric Oxide for the Treatment of Neonatal Hypoxic Respiratory Failure With Pulmonary Hypertension

NCT06901050Not ApplicableRecruitingPrimary

Effect of FAST HUGS WITH ICU Approach on Length of Intensive Care Unit Stay in Patients With Hypoxic Respiratory Failure

NCT06336265Not Yet RecruitingPrimary

Diaphragmatic Ultrasound to Predict the Therapeutic Effect of High-flow Nasal Cannula Oxygen Therapy

NCT06043635Withdrawn

Predictors of Inhaled Nitric Oxide Responsiveness in Patients With PPHN

NCT05689216Not ApplicableUnknown

Timed Awake Prone and Repositioning for Patients With Covid-19-induced Hypoxic Respiratory Failure.

NCT04344561Not ApplicableTerminated

Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation

NCT04648657CompletedPrimary

Lung Ultrasound, PEEP and Overdistension (LUPO)

NCT01069861Phase 2Terminated

Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN)

NCT04433546Phase 2Terminated

Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).

NCT04380727Completed

Almitrine and COVID-19 Related Hypoxemia

NCT04385823Completed

Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure

NCT04049240Not ApplicableUnknown

Effect of HFNO on Spontaneous Ventilation in Obese Patients During Analgo-sedation for Vitrectomy

NCT02184208Completed

Retrospective Review of Mechanically Ventilated Patients Using a Continuous Data Collection System.

NCT03082105Not ApplicableCompletedPrimary

Snow Physical Properties and Human Ventilatory Response

Showing all 18 trials

Research Network

Activity Timeline